17
Participants
Start Date
July 31, 2006
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2011
escitalopram
Escitalopram: wk 1: 10 mg/d; wks 2-3: 20 mg/d; wk4: 30 mg/d; wks 5-6: 40 mg/d
bupropion
bupropion XL 150 mg/d increasing as tolerated and not remitted by 150 mg/d to maximal dose of 450 mg/d
imipramine
imipramine 50 mg/d increasing twice weekly by 50 mg/increase to 200 mg/d, then 50 mg increase/week to 300 mg/d; all dose increases if tolerated and not remitted
New York State Psychiatric Institute, New York
New York State Psychiatric Institute
OTHER